Clinical Trial

Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk

Study acronym: EMeRiT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will show the value of early genetic diagnosis in the case of MEG in a child and may lead to recommendations aimed at preventing tumor risk based on a simple and easily accessible clinical criterion (the measurement of head circumference). Ultimately, this study may improve cancer prognosis in the population of children with MEG.
Trial Details
NCT Number NCT07142772
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Megalocephaly
Enrollment 200 participants
Start Date 2025-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-27